SANUWAVE Health, Inc.
Cash Flow Statement
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $11.8M | $-33.1M | $-25.8M | $-10.3M | $-27.3M | $-30.9M | $-10.4M | $-11.6M |
| Depreciation & Amortization | $974.0K | $788.0K | $1.0M | $952.0K | $1.2M | $299.0K | $71.2K | — |
| Depreciation | $392.0K | $305.0K | — | — | $182.0K | $98.0K | $37.7K | $22.3K |
| Amortization | $704.0K | $704.0K | $704.0K | $704.0K | $704.0K | $713.0K | $0 | — |
| Stock-Based Compensation | $4.9M | $1.5M | $0 | — | $0 | $22.0K | $333.4K | $2.5M |
| Net Cash from Operating Activities | $3.9M | $2.5M | $-4.5M | $-17.2M | $-6.4M | $-12.7M | $-6.4M | $-3.6M |
| Investing Activities | ||||||||
| Capital Expenditures | $1.9M | $490.0K | $0 | — | $529.0K | $53.0K | $53.9K | $42.9K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $3.4M | $-490.0K | $21.0K | $332.0K | $-529.0K | $-20.1M | $-53.9K | $-42.9K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $-5.6M | $6.4M | $5.2M | $17.4M | $5.1M | $33.4M | $7.9M | $3.3M |
| Net Change in Cash | $1.7M | $8.4M | $644.0K | $534.0K | $-1.8M | $676.0K | $1.4M | $-365.6K |
| Free Cash Flow | $1.9M | $2.0M | $-4.5M | — | $-6.9M | $-12.8M | $-6.5M | $-3.7M |